[Low molecular-weight heparin (clexane) in the prevention of thrombotic events in patients with malignancies].

Somonova, O V; Madzhuga, A V; Elizarova, A L; Sel'chuk, V Iu; Zubrikhina, G N; Bokhian, A Iu

Somonova, O V; Madzhuga, A V; Elizarova, A L; Sel'chuk, V Iu; Zubrikhina, G N; Bokhian, A Iu.

Klin Lab Diagn ; (8): 31-3, 2006 Aug.

Article in Ru | MEDLINE | ID: mdl-17087245

Subject(s)

Enoxaparin/therapeutic use; Neoplasms/complications; Postoperative Complications/prevention & control; Venous Thrombosis/prevention & control; Heparin, Low-Molecular-Weight/therapeutic use; Humans; Neoplasms/surgery; Postoperative Care; Preoperative Care; Venous Thrombosis/complications

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Enoxaparin / Venous Thrombosis / Neoplasms Type of study: Clinical_trials Limits: Humans Language: Ru Journal: Klin Lab Diagn Journal subject: TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2006 Type: Article

Search on Google

XML

PubMed Links